Ignite Creation Date:
2025-12-24 @ 7:25 PM
Ignite Modification Date:
2026-01-01 @ 11:52 PM
Study NCT ID:
NCT00708903
Status:
COMPLETED
Last Update Posted:
2012-05-14
First Post:
2008-06-27
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study to Examine the Effect of HKI-272 on Rhythms of the Heart (Cardiac Repolarization)
Sponsor:
Puma Biotechnology, Inc.
Organization:
Study Overview
Official Title:
A Single Dose, Crossover, Placebo- and Moxifloxacin-Controlled Study of the Effects of HKI-272 on Cardiac Repolarization in Healthy Adult Subjects
Status:
COMPLETED
Status Verified Date:
2012-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to determine whether HKI-272 affects the rhythms of the heart (cardiac repolarization).
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: